Company profile ANNX

Annexon Inc
our mission is to develop disease-modifying therapeutics for patients suffering from neurological disorders such as huntington’s disease and alzheimer’s disease by targeting complement-mediated neurodegeneration (cmnd).
Quarter analysis & expected interest

There is not enough data for Annexon, Inc. to provide analysis

Correlation between past revenue and Annexon, Inc. search interest

There is not enough data for Annexon, Inc. to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Annexon, Inc. to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Annexon, Inc. therapeutics to provide analysis

Correlation between past revenue and Annexon, Inc. therapeutics search interest

There is not enough data for Annexon, Inc. therapeutics to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Annexon, Inc. therapeutics to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for ANX005 clinical trials to provide analysis

Correlation between past revenue and ANX005 clinical trials search interest

There is not enough data for ANX005 clinical trials to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for ANX005 clinical trials to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for ANX009 lupus nephritis to provide analysis

Correlation between past revenue and ANX009 lupus nephritis search interest

There is not enough data for ANX009 lupus nephritis to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for ANX009 lupus nephritis to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for ANX007 geographic atrophy to provide analysis

Correlation between past revenue and ANX007 geographic atrophy search interest

There is not enough data for ANX007 geographic atrophy to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for ANX007 geographic atrophy to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for ANX105 neurodegenerative diseases to provide analysis

Correlation between past revenue and ANX105 neurodegenerative diseases search interest

There is not enough data for ANX105 neurodegenerative diseases to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for ANX105 neurodegenerative diseases to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for ANX1502 autoimmune indications to provide analysis

Correlation between past revenue and ANX1502 autoimmune indications search interest

There is not enough data for ANX1502 autoimmune indications to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for ANX1502 autoimmune indications to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Annexon, Inc. stock to provide analysis

Correlation between past revenue and Annexon, Inc. stock search interest

There is not enough data for Annexon, Inc. stock to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Annexon, Inc. stock to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Annexon, Inc. contact information to provide analysis

Correlation between past revenue and Annexon, Inc. contact information search interest

There is not enough data for Annexon, Inc. contact information to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Annexon, Inc. contact information to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Annexon, Inc. careers to provide analysis

Correlation between past revenue and Annexon, Inc. careers search interest

There is not enough data for Annexon, Inc. careers to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Annexon, Inc. careers to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Useful links and data for ANNX
Earnings date: 2024-03-04 After close
Company name: Annexon Inc
Sector: Manufacturing
Company's website
Hypercharts
Yahoo Finance
MarketWatch
StockTwits
SEC Filings
SwaggyStocks
Latest articles

2026-05-12T10:04:02Z

Analyst Upgrades
Goldman Sachs Initiates Coverage On Annexon with Neutral Rating, Announces Price Target of $7

2026-05-11T14:00:00Z

GlobeNewswire
110 Years. 110 Stories. 110 Reasons to Raise Awareness for GBS

2026-05-07T20:01:00Z

GlobeNewswire
Annexon Reports First Quarter 2026 Financial Results, Portfolio Progress and Key Anticipated Milestones

2026-05-06T12:00:00Z

GlobeNewswire
Annexon to Present at the Bank of America Securities Health Care Conference 2026

2026-04-08T20:05:00Z

GlobeNewswire
Annexon to Present at the 25th Annual Needham Virtual Healthcare Conference

2026-03-30T20:01:00Z

GlobeNewswire
Annexon Reports Fourth Quarter and Year-End 2025 Financial Results, Portfolio Progress and Key Anticipated Milestones

2026-03-16T20:05:00Z

GlobeNewswire
Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)

2026-02-24T13:00:00Z

GlobeNewswire
Annexon Biosciences to Present at the TD Cowen 46th Annual Health Care Conference

2026-02-17T13:00:00Z

GlobeNewswire
Annexon to Host In-Person and Virtual KOL Event to Discuss Vonaprument for the Treatment of Geographic Atrophy

2026-01-16T22:05:12Z

GlobeNewswire
Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)

2026-01-12T12:00:00Z

GlobeNewswire
Annexon Accelerating Next Generation Targeted Immunotherapy Platform for Treatment of Neuroinflammatory Diseases with Multiple Registrational Milestones in 2026

2026-01-08T13:00:00Z

GlobeNewswire
Annexon Submits Tanruprubart Marketing Authorization Application to the European Medicines Agency for Guillain-Barré Syndrome

2026-01-07T21:05:00Z

GlobeNewswire
Annexon Biosciences to Present at the 44th Annual J.P. Morgan Healthcare Conference

2025-12-23T13:52:26Z

Analyst Upgrades
Chardan Capital Initiates Coverage On Annexon with Buy Rating, Announces Price Target of $16

2025-12-17T00:31:15Z

GlobeNewswire
Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)